rs147412276
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173689.7(CRB2):c.3746G>A(p.Arg1249Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000724 in 1,606,200 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_173689.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRB2 | ENST00000373631.8 | c.3746G>A | p.Arg1249Gln | missense_variant | Exon 13 of 13 | 1 | NM_173689.7 | ENSP00000362734.3 | ||
CRB2 | ENST00000460253.1 | n.2750G>A | non_coding_transcript_exon_variant | Exon 8 of 9 | 2 | ENSP00000435279.1 |
Frequencies
GnomAD3 genomes AF: 0.000881 AC: 134AN: 152170Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00138 AC: 319AN: 231990Hom.: 4 AF XY: 0.00132 AC XY: 166AN XY: 126206
GnomAD4 exome AF: 0.000708 AC: 1029AN: 1454030Hom.: 10 Cov.: 31 AF XY: 0.000709 AC XY: 512AN XY: 722586
GnomAD4 genome AF: 0.000881 AC: 134AN: 152170Hom.: 1 Cov.: 33 AF XY: 0.000928 AC XY: 69AN XY: 74328
ClinVar
Submissions by phenotype
Focal segmental glomerulosclerosis 9 Pathogenic:1Uncertain:1
- -
NM_173689.5:c.3746G>A in the CRB2 gene has an allele frequency of 0.025 in Ashkenazi Jewish subpopulation in the gnomAD database. 4 homozygous occurrences are observed in the gnomAD database. Ebarasi et al. reported a homozygozity in a patient with Steroid-Resistant Nephrotic Syndrome in a consanguineous family (PMID: 25557779). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BS1. -
not provided Benign:2
- -
See Variant Classification Assertion Criteria. -
Inborn genetic diseases Uncertain:1
The c.3746G>A (p.R1249Q) alteration is located in exon 13 (coding exon 13) of the CRB2 gene. This alteration results from a G to A substitution at nucleotide position 3746, causing the arginine (R) at amino acid position 1249 to be replaced by a glutamine (Q). The in silico prediction for the p.R1249Q alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at